We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 26th:
Arbor Realty Trust, Inc. (ABR - Free Report) : This real estate investment trust and national direct lenderhas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
YAMANA GOLD INC. : This precious metals producer with significant gold and silver production has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 75% over the last 60 days.
Amgen (AMGN - Free Report) : This developer and manufacturer of innovative human therapeutics has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for August 26th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 26th:
Arbor Realty Trust, Inc. (ABR - Free Report) : This real estate investment trust and national direct lenderhas a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Arbor Realty Trust Price and Consensus
Arbor Realty Trust price-consensus-chart | Arbor Realty Trust Quote
Arbor Realty's shares gained 2.2% over the last one month compared to S&P 500’s fall of -5.8%. The company possesses a Momentum Score of B.
Arbor Realty Trust Price
Arbor Realty Trust price | Arbor Realty Trust Quote
YAMANA GOLD INC. : This precious metals producer with significant gold and silver production has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 75% over the last 60 days.
Yamana Gold Inc. Price and Consensus
Yamana Gold Inc. price-consensus-chart | Yamana Gold Inc. Quote
YAMANA's shares gained 23.1% over the last one month. The company possesses a Momentum Score of A.
Yamana Gold Inc. Price
Yamana Gold Inc. price | Yamana Gold Inc. Quote
Amgen (AMGN - Free Report) : This developer and manufacturer of innovative human therapeutics has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.
Amgen Inc. Price and Consensus
Amgen Inc. price-consensus-chart | Amgen Inc. Quote
Amgen’s shares gained 13.1% over the last one month. The company possesses a Momentum Score of A.
Amgen Inc. Price
Amgen Inc. price | Amgen Inc. Quote
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote
ACADIA’s shares gained 16.5% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>